Mayo Clinic

Gastroenterology

Darrell Pardi works in the field of Gastroenterology. He researched medicine at University of Rochester School of Medicine and Dentistry. He received 1 awards: "Regional Top Doctor". Darrell S. Pardi is also published. He has 21 publications published. The lastest publication: "A Novel Microbiome Therapeutic Increases Gut Microbial Diversity and Prevents Recurrent Clostridium difficile Infection.'

Publications

---

• Clinical implications of antibiotic impact on gastroIntestinal microbiota and Clostridium difficile Infection.
• A Novel Microbiome Therapeutic Increases Gut Microbial Diversity and Prevents Recurrent Clostridium difficile Infection.
• American Gastroenterological Association Institute Technical Review on the Medical Management of Microscopic Colitis.
• Letter: clinical predictors of Clostridium difficile infection - advanced age and residential status are important factors for prediction and prevention - authors' reply.
• Comparative efficacy of pharmacologic interventions in preventing relapse of Crohn's disease after surgery: a Systematic review and network meta-analysis.
• Epidemiology, risk factors and management of cardiovascular Diseases in IBD.
• Update on anti-tumor necrosis factor agents in Crohn Disease.
• Reply to Theocharidou et al - Letter to the Editor.
• Clinical predictors of recurrent Clostridium difficile infection in out-patients.
• Outcomes from Rectal Vancomycin Therapy in Patients With Clostridium difficile Infection.
• The epidemiology of microscopic colitis in olmsted county from 2002 to 2010: a population-based study.
• Clinical characteristics and imaging features of small bowel adenocarcinomas in Crohn's Disease.
• Risk of Cerebrovascular Accidents and Ischemic Heart Disease in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
• Clostridium difficile infection: management strategies for a difficult Disease.
• Inflammatory Bowel Disease is Associated with an Increased Risk of Melanoma: A Systematic Review and Meta-Analysis.
• Validation of a CT-Derived Method for Osteoporosis Screening in IBD Patients Undergoing Contrast-Enhanced CT Enterography.
• Letter: effectiveness of split-dose certolizumab pegol for Crohn's Disease.
• The fate of indefinite and low-grade dysplasia in Ulcerative colitis and primary sclerosing cholangitis colitis before and after liver transplantation.
• Meta-analysis: serological markers and the risk of acute and chronic pouchitis.
• Natalizumab for moderate to severe Crohn's Disease in clinical practice: The Mayo Clinic Rochester experience.

Schools

---

• University Of Rochester School Of Medicine and Dentistry

• University Rochester

• Rochester Genl Hospital

• Mayo Clinic

Procedures Preformed

---

• Biliary Drainage
• Colonoscopy, Proctosigmoidoscopy, and Sigmoidoscopy
• Endoscopy (Esophagus, Stomach, Small Intestine)
• ERCP (Endoscopic Retrograde Cholangiopancreatography)

Conditions Treated

---

• Abdominal Pain
• Anemia
• Barrett's Esophagus
• Benign Neoplasm of the Digestive System
• View All

Doctors Specialties

---

• Gastroenterology

Accepted Insurances

---

Awards

---

• Regional Top Doctor

Education

---

• Mayo School of Graduate Medical Education
• University of Rochester
• University of Rochester School of Medicine and Dentistry

Hospital

---

• Mayo Clinic - Rochester, Minnesota

Helpful Reviews

---

Give Anonymous Review

Similar Doctors

---

	Dr. Nayantara Coelho-Prabhu, MD This Doctor is OpenDoctor Recommended.
	Dr. Johanna C. Iturrino, MD This Doctor is OpenDoctor Recommended.
	Dr. Rajesh Krishnamoorthi, MD This Doctor is OpenDoctor Recommended.
	Dr. Dawn D. Ferguson, MD
	Dr. Yuri A. Saito Loftus, MD
	Dr. Margot L. Herman, MD
	Dr. Shiv K. Desai, MD This Doctor is OpenDoctor Recommended.
	Dr. Michael J. Levy, MD This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog